The Annexure

News to 9 October 2026 ·

Desk›Healthcare› AstraZeneca Pharma India Ltd

AstraZeneca Pharma India Ltd

BSE 506820 · NSE ASTRAZEN · ISIN INE203A01020 · Group A · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹7,121.10

-0.48%

BSE close, 28 August 2026

Market cap

₹17,802.75 cr

2.5 cr shares · Small cap

Free float

₹4,385.46 cr

as published

P/E · P/B

105.0× · 26.21×

EPS ₹67.85 · BV ₹271.69

FY25-26 rev / PAT

2,275.58 / 187.52

₹ cr, as filed

Filings, window

19

5 selected · 26%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹7,075.00 52-WK HIGH ₹9,850.00 ₹7,121.10 2% of range
Against 52-week high-27.7%
Against 52-week low+0.7%
Day change-0.48%
Size bandSmall cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹67.85
Price / earnings104.95×
Price / book26.21×
Book value — derived, price ÷ P/B₹271.69
Return on equity24.97%
Operating margin8.48%
Net margin5.56%

Consistency check

P/B ÷ P/E, which must equal ROE
24.97%
ROE as published
24.97%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 682.79 37.93 15.17 8.48% 5.56%
Mar-26 · Q 578.61 44.88 17.95 11.37% 7.76%
FY25-26 2,275.58 187.52 75.01 12.54% 8.24%

Quarter on quarter

Revenue, quarter on quarter
+18.0%
Net profit, quarter on quarter
-15.5%
Operating margin, quarter on quarter
-289 bps

Disclosure profile 19 filings in the window

0 median 17.0 p75 · 25 sector max 52 19 58th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Order / Contract2
KMP1
Press Release1
Results1
Selected sub-total5
Procedural
General7
AGM / EGM2
Analyst / Investor Meet1
Board Meeting1
Compliance Certificate1
Newspaper Publication1
Trading Window1
Procedural sub-total14
Total19

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group A, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

19 filings · 5 selected · busiest 2026-07-28 and 2026-08-10

Filing rhythm · the twelve most recent

2026-08-042026-09-18

SelectedProcedural

Filings

19 in the window · 8 earlier on record

  1. 18 September 2026 ·

    Order / Contract

    Award_of_Order_Receipt_of_Order

    Please find the enclosed intimation of the Company with respect to the captioned subject for your reference.

    Company Update / Award of Order / Receipt of Order View filing →

  2. 15 September 2026 ·

    Trading Window

    Closure of Trading Window

    Please find the enclosed intimation of the Company as per the captioned subject for your reference.

    Insider Trading / SAST / Closure of Trading Window View filing →

  3. 15 September 2026 ·

    General

    Information Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Resignation Of Senior Management Personnel

    Please find the enclosed intimation of the Company in relation to the captioned subject for your reference.

    Company Update / General View filing →

  4. 2 September 2026 ·

    General

    Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Disclosure Of ESG Rating

    Please find the enclosed intimation of the Company as per the captioned subject for your reference.

    Company Update / General View filing →

  5. 25 August 2026 ·

    Order / Contract

    Award_of_Order_Receipt_of_Order

    Please find the enclosed document of the Company in relation to the captioned subject for your reference.

    Company Update / Award of Order / Receipt of Order View filing →

  6. 24 August 2026 ·

    General

    Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Disclosure Of ESG Rating

    Please find the enclosed intimation of the Company in relation to the captioned subject for reference.

    Company Update / General View filing →

  7. 21 August 2026 ·

    Analyst / Investor Meet

    Analyst / Investor Meet - Intimation

    Please find the enclosed intimation of the Company in relation to the captioned subject for your reference.

    Company Update / Analyst / Investor Meet View filing →

  8. 12 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Please find the enclosed intimation of the Company as per the captioned subject for your reference.

    AGM/EGM / AGM View filing →

  9. 11 August 2026 ·

    Press Release

    Press Release / Media Release

    Please find the enclosed Press Release of the Company for your reference.

    Company Update / Press Release / Media Release View filing →

  10. 10 August 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Please find the enclosed intimation of the Company as per the captioned subject for your reference.

    AGM/EGM / AGM View filing →

  11. 10 August 2026 ·

    Results

    Outcome Of The Board Meeting Held On Monday, August 10, 2026

    Please find the enclosed intimation of the Company as per the captioned subject for your reference.

    Result / Financial Results View filing →

  12. 4 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Monday, August 10, 2026

    Astrazeneca Pharma India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve This is to inform ....

    Board Meeting / Board Meeting View filing →

  13. 30 July 2026 ·

    General

    Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please find the enclosed document of the Company in relation to the captioned subject for your reference.

    Company Update / General View filing →

  14. 29 July 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Please find the enclosed intimation of the Company as per the captioned subject for your reference.

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

  15. 28 July 2026 ·

    General

    Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

    Please find the enclosed intimation of the Company as per the captioned subject for your reference.

    Company Update / General View filing →

  16. 28 July 2026 ·

    General

    Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation, 2015

    Please find the enclosed letter of the Company as per the captioned subject for your reference.

    Company Update / General View filing →

  17. 22 July 2026 ·

    General

    Communication To The Shareholders W.R.T. TDS On Dividend

    Please find the enclosed intimation of the Company as per the captioned subject for your reference.

    Company Update / General View filing →

  18. 21 July 2026 ·

    KMP

    Resignation of Chief Financial Officer (CFO)

    Please find the enclosed intimation of the Company as per the captioned subject for your reference.

    Company Update / Resignation of Chief Financial Officer (CFO) View filing →

  19. 20 July 2026 ·

    Newspaper Publication

    Newspaper Publication

    Please find the enclosed intimation of the Company as per the captioned subject for your reference.

    Company Update / Newspaper Publication View filing →

RSS feed for AstraZeneca Pharma India Ltd · the 50 most recent filings